Airway function indicators and blood indicators in children with dust mite allergic rhinitis after sublingual immunotherapy

Airway function indicators and blood indicators in children with dust mite allergic rhinitis after sublingual immunotherapy

Objective: To evaluate the airway function indicators and blood indicators in children with dust mite allergic rhinitis after sublingual immunotherapy. Methods: A total of 68 children with dust mite allergic rhinitis treated in our hospital from November, 2012 to October, 2015 were selected as th...

Full description

Bibliographic Details
Main Author:	Hua Xiang
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-07-01
Series:	Journal of Hainan Medical University
Subjects:	Dust mite allergic rhinitis Sublingual immunotherapy
Online Access:	http://www.hnykdxxb.com/PDF/201613/29.pdf

Similar Items

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
by: Anne K. Ellis, et al.
Published: (2019-04-01)

Sublingual Immunotherapy with House Dust Extract for House Dust-Mite Allergic Rhinitis in Children
by: Syuji Yonekura, et al.
Published: (2010-01-01)

Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
by: Shaobing Xie, et al.
Published: (2021-07-01)

Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life
by: Silviya Mihaylova Novakova, et al.
Published: (2017-09-01)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
by: Omar Ali Aboshady, et al.
Published: (2014-12-01)

Effect of sublingual immunotherapy combined with Loratadine on blood parameters and induced sputum indicators in children with allergic rhinitis
by: Ling He, et al.
Published: (2016-05-01)

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
by: Andrzej Bożek, et al.
Published: (2017-12-01)

Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials
by: Yi Li, et al.
Published: (2018-01-01)

Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
by: Yanran Huang, et al.
Published: (2019-12-01)

The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis
by: M.P. Prokhorova
Published: (2015-09-01)

Determinants and Factors of Satisfaction with Sublingual Immunotherapy in Patients with Allergic Rhinitis
by: Silviya Novakova
Published: (2020-06-01)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
by: Hyun Chang, et al.
Published: (2009-09-01)

Efficacy of Sublingual Swallow Immunotherapy in Children with Rye Grass Pollen Allergic Rhinitis: A Double-blind Placebo-Controlled Study
by: Akefeh Ahmadiafshar, et al.
Published: (2012-06-01)

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
by: Hongfei Lou, et al.
Published: (2020-09-01)

Effect of sublingual dust mite drops on pulmonary function, immunoglobulin and T lymphocyte subsets in patients with allergic rhinitis
by: Yang-Jun Liu, et al.
Published: (2018-07-01)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
by: Ioana Adriana Muntean, et al.
Published: (2020-05-01)

Long-term effects of allergen sublingual immunotherapy
by: Andrzej Bozek, et al.
Published: (2019-05-01)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
by: Yaqi Yang, et al.
Published: (2021-04-01)

Research on allergic rhinitis improvement in asthmatic children after dust mite exposure reduction: a randomized, double-blind, cross-placebo study protocol
by: Ming Chen, et al.
Published: (2020-07-01)

Sublingual immunotherapy in mite-sensitized patients with atopic dermatitis: a randomized controlled study
by: Nansheng Yu, et al.
Published: (2021-03-01)

Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study
by: Alberto Vieira-Hernández, et al.
Published: (2018-04-01)

Precision Medicine in House Dust Mite-Driven Allergic Asthma
by: Ibon Eguiluz-Gracia, et al.
Published: (2020-11-01)

Efficacy and safety of sublingual immunotherapy in children aged 6-24 months with rhinitis and bronchial asthma sensitized to house dust mites
by: Olimpio Rodríguez-Santos, et al.
Published: (2015-11-01)

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
by: Damien Leger, et al.
Published: (2017-08-01)

Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
by: Da-Chuan Fan, et al.
Published: (2016-01-01)

Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
by: Anne K. Ellis, et al.
Published: (2021-07-01)

Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts
by: Kenjiro Shima, et al.
Published: (2017-01-01)

Application analysis of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma
by: Xia Zhao
Published: (2017-04-01)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
by: Thomas Proctor, et al.
Published: (2020-04-01)

Sublingual Immunotherapy
by: Ferrell, Melissa Leann
Published: (2015)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
by: Vogelberg C, et al.
Published: (2020-05-01)

Role of IL-22 in persistent allergic airway diseases caused by house dust mite: a pilot study
by: Laura Tamasauskiene, et al.
Published: (2021-01-01)

Efficacy of Sublingual Immunotherapy with Dermatophagoides Pteronyssinus: A Real-life Study
by: Tomic-Spiric Vesna, et al.
Published: (2016-04-01)

Nasal IgE in subjects with allergic and non-allergic rhinitis
by: Jonas Eckrich, et al.
Published: (2020-06-01)

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children
by: Wang L, et al.
Published: (2021-07-01)

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
by: Patrick Blin, et al.
Published: (2018-09-01)

Practice parameters for sublingual immunotherapy
by: C. Ortolani, et al.
Published: (2016-02-01)

Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: A case series
by: Carlo Cavaliere, et al.
Published: (2020-11-01)

Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis
by: Živković Zorica, et al.
Published: (2016-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Cannot write session to /tmp/vufind_sessions/sess_bl3pbj0e9s3fiof9d238a2a2n7